| Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways Softcover Repri Edition Contributor(s): Yarden, Yosef (Editor), Elkabets, Moshe (Editor) |
|
 |
ISBN: 3030098176 ISBN-13: 9783030098179 Publisher: Springer OUR PRICE: $161.49 Product Type: Paperback - Other Formats Published: February 2019 |
| Additional Information |
| BISAC Categories: - Medical | Oncology - General - Medical | Forensic Medicine |
| Dewey: 614.599 |
| Series: Resistance to Targeted Anti-Cancer Therapeutics |
| Physical Information: 0.55" H x 6.14" W x 9.21" (0.82 lbs) 242 pages |
| Descriptions, Reviews, Etc. |
| Publisher Description: This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance. |